Financial reports
10-K
2023 FY
Annual report
23 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
25 Feb 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
Current reports
8-K
Other Events
23 Feb 24
8-K
Departure of Directors or Certain Officers
8 Dec 23
8-K
Other Events
7 Dec 23
8-K
Departure of Directors or Certain Officers
15 Aug 23
8-K
Other Events
4 Aug 23
8-K
Departure of Directors or Certain Officers
6 Jun 23
8-K
Departure of Directors or Certain Officers
5 Jun 23
8-K
Amendments to Articles of Incorporation or Bylaws
3 Apr 23
8-K
Other Events
16 Mar 23
8-K
Departure of Directors or Certain Officers
10 Mar 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
16 Mar 23
S-3ASR
Automatic shelf registration
16 Mar 23
424B5
Prospectus supplement for primary offering
30 Nov 22
FWP
Free writing prospectus
29 Nov 22
424B5
Prospectus supplement for primary offering
29 Nov 22
424B2
Prospectus for primary offering
26 Sep 22
FWP
Free writing prospectus
22 Sep 22
424B5
Prospectus supplement for primary offering
22 Sep 22
S-3ASR
Automatic shelf registration
17 Mar 20
424B2
Prospectus for primary offering
12 Jun 19
Proxies
No filings
Other
UPLOAD
Letter from SEC
9 Jun 22
CORRESP
Correspondence with SEC
27 May 22
UPLOAD
Letter from SEC
23 May 22
CT ORDER
Confidential treatment order
19 Mar 19
UPLOAD
Letter from SEC
25 Jul 17
UPLOAD
Letter from SEC
1 Nov 16
CORRESP
Correspondence with SEC
28 Sep 16
UPLOAD
Letter from SEC
16 Sep 16
CT ORDER
Confidential treatment order
26 Apr 16
EFFECT
Notice of effectiveness
5 Feb 16